PPG's strategic legal advice transformed Volumina Medical’s groundbreaking, regenerative medical research into a robust patent portfolio.
Volumina Medical (Volumina), a pioneer in regenerative medicine, is redefining treatment in reconstructive and plastic surgery with innovative biomaterials. Derived from extensive research at the Swiss Federal Institute of Technology and developed in consultation with leading surgeons, its flagship product, AdiPearl™, offers a minimally invasive solution to durably reconstruct soft tissue volumes.
Each year, millions endure the permanent loss of soft tissue due to trauma, surgery, or aging. Those impacted experience significant functional and cosmetic challenges. Traditional treatment methods fall short, failing to restore tissue effectively. Volumina’s innovative approach to soft tissue repair, which uses a single-injection, minimally invasive biomaterial scaffold to repair the deficient area and add 3D volume in a single session, faced hurdles in receiving a patent. Initial efforts prior to engaging Pabst Patent Group (PPG), resulted in repeated rejections and stalled applications at the patent office.
In 2020, Volumina turned to PPG, drawn by a unique blend of high-level strategic insight and deep technical experience across various scientific and medical disciplines. PPG overcame the initial patent setbacks and significantly advanced Volumina's patent portfolio to secure three crucial patents, with two more patent applications pending.
The partnership between PPG and Volumina enhanced Volumina’s market position. PPG’s comprehensive approach enabled Volumina to safeguard its intellectual property assets and position itself as a leader in a highly competitive industry.
By aligning legal strategies with Volumina’s innovative vision, PPG helped turn cutting-edge research into commercially viable, protected healthcare solutions. The collaboration between PPG and Volumina showcases how strategic legal counsel, informed by long-term client goals, is vital for the success of tech-based startups.